×
About 3,483 results

ALLMedicine™ Medullary Thyroid Carcinoma Center

Research & Reviews  1,717 results

Multiple endocrine neoplasia 2A with RET mutation p.Cys611Tyr: A case report.
https://doi.org/10.1097/MD.0000000000026230
Medicine Li Y, Tan YQ et. al.

Jun 4th, 2021 - Multiple endocrine neoplasia 2A (MEN2A) is a rare autosomal-dominant genetic syndrome, frequently misdiagnosed or neglected clinically, resulting in delayed therapy to patients. A 47-year-old Chinese male patient underwent laparoscopic right adren...

Efficacy and safety of peptide receptor radionuclide therapy in advanced radioiodine-re...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139052
BMC Cancer; Maghsoomi Z, Emami Z et. al.

May 21st, 2021 - It has been shown that a subgroup of patients with differentiated thyroid cancer (DTC) and medullary thyroid carcinoma (MTC) would progress to advanced stages of thyroid cancer. Therefore, the present study was done to systematically review availa...

Ultrasound features and risk stratification systems to identify medullary thyroid carci...
https://doi.org/10.1530/EJE-21-0313
European Journal of Endocrinology; Matrone A, Gambale C et. al.

May 19th, 2021 - Recently, several scientific societies designed ultrasound (US) risk stratification systems (RSS) to guide the work-up of thyroid nodules and decide which nodules should undergo fine needle aspiration cytology (FNAC). However, these systems have b...

see more →

Guidelines  2 results

Consensus on management of advanced medullary thyroid carcinoma on behalf of the Workin...
https://doi.org/10.1007/s12094-015-1465-x
Clinical & Translational Oncology : Official Publication ... Grande E, Santamaría Sandi J et. al.

Dec 21st, 2015 - Of all thyroid cancers, <5 % are medullary (MTC). It is a well-characterized neuroendocrine tumor arising from calcitonin-secreting C cells, and RET gene plays a central role on its pathogeny. The electronic search was conducted using MEDLINE (Pub...

Revised American Thyroid Association guidelines for the management of medullary thyroid...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490627
Thyroid : Official Journal of the American Thyroid Associ... Wells SA, Asa SL et. al.

Mar 26th, 2015 - The American Thyroid Association appointed a Task Force of experts to revise the original Medullary Thyroid Carcinoma: Management Guidelines of the American Thyroid Association. The Task Force identified relevant articles using a systematic PubMed...

see more →

Clinicaltrials.gov  1,743 results

Multiple endocrine neoplasia 2A with RET mutation p.Cys611Tyr: A case report.
https://doi.org/10.1097/MD.0000000000026230
Medicine Li Y, Tan YQ et. al.

Jun 4th, 2021 - Multiple endocrine neoplasia 2A (MEN2A) is a rare autosomal-dominant genetic syndrome, frequently misdiagnosed or neglected clinically, resulting in delayed therapy to patients. A 47-year-old Chinese male patient underwent laparoscopic right adren...

Efficacy and safety of peptide receptor radionuclide therapy in advanced radioiodine-re...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139052
BMC Cancer; Maghsoomi Z, Emami Z et. al.

May 21st, 2021 - It has been shown that a subgroup of patients with differentiated thyroid cancer (DTC) and medullary thyroid carcinoma (MTC) would progress to advanced stages of thyroid cancer. Therefore, the present study was done to systematically review availa...

Ultrasound features and risk stratification systems to identify medullary thyroid carci...
https://doi.org/10.1530/EJE-21-0313
European Journal of Endocrinology; Matrone A, Gambale C et. al.

May 19th, 2021 - Recently, several scientific societies designed ultrasound (US) risk stratification systems (RSS) to guide the work-up of thyroid nodules and decide which nodules should undergo fine needle aspiration cytology (FNAC). However, these systems have b...

see more →

News  21 results

BLU-667: New Hope for NSCLC and Medullary Thyroid Cancer
https://www.staging.medscape.com/viewarticle/895225

Apr 15th, 2018 - CHICAGO — Point mutations or gene rearrangements in the receptor tyrosine kinase proto-oncogene RET have been seen in several tumors, including medullary thyroid carcinoma (MTC) and non–small cell lung cancer (NSCLC). However, there are no approve...

BLU-667: New Hope for NSCLC and Medullary Thyroid Cancer
https://www.medscape.com/viewarticle/895225

Apr 15th, 2018 - CHICAGO — Point mutations or gene rearrangements in the receptor tyrosine kinase proto-oncogene RET have been seen in several tumors, including medullary thyroid carcinoma (MTC) and non–small cell lung cancer (NSCLC). However, there are no approve...

Scapular rash and endocrine neoplasia
https://www.mdedge.com/ccjm/article/150352/dermatology/scapular-rash-and-endocrine-neoplasia?channel=162
Muhammed Razmi T, MD, DNB, Debajyoti Chatterjee, MD et. al.

Nov 1st, 2017 - A woman in her 30s presented with an itchy skin-colored rash over her left scapular region that had first appeared 8 years earlier. It had started as itchy skin-colored papules that coalesced to a patch and later became hyperpigmented because of r.

Thyroid Ca: Initial Neck Dissection May Cut Recurrence Risk
https://www.medpagetoday.com/endocrinology/thyroid/68165

Sep 27th, 2017 - Action Points Among those with medullary thyroid carcinoma (MTC), lymph node dissection seemed to decrease local recurrences. Note that guidelines from the American Thyroid Association recommend all patients with known MTC undergo surgery to remov...

Renal cell carcinoma approval adds another notch to cabozantinib’s belt
https://www.mdedge.com/hematology-oncology/article/118588/genitourinary-cancer/renal-cell-carcinoma-approval-adds-another
Edited by Jame Abraham, MD et. al.

Nov 21st, 2016 - In April this year, the US Food and Drug Administration awarded regulatory approval to cabozantinib for the treatment of advanced renal cell carcinoma patients previously treated with anti-angiogenic therapy. 1 The small-molecule inhibitor, which.

see more →